Redhill Biopharma
RDHL
#11144
Rank
โ‚น0.27 B
Marketcap
โ‚น31.34
Share price
-4.17%
Change (1 day)
-66.01%
Change (1 year)

Redhill Biopharma (RDHL) - Cash on Hand

Cash on Hand as of June 2026 : โ‚น0.48 Billion

According to Redhill Biopharma's latest financial reports the company has โ‚น0.48 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Redhill Biopharma - Cash on Hand chart (from 2011 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚น0.35 B-10%
2024-12-31โ‚น0.39 B-14.57%
2023-12-31โ‚น0.46 B-71.96%
2022-12-31โ‚น1.65 B-41.54%
2021-12-31โ‚น2.82 B29.82%
2020-12-31โ‚น2.17 B-36.17%
2019-12-31โ‚น3.41 B-8.2%
2018-12-31โ‚น3.71 B26.05%
2017-12-31โ‚น2.95 B-34.37%
2016-12-31โ‚น4.49 B16.36%
2015-12-31โ‚น3.86 B165.68%
2014-12-31โ‚น1.45 B94.32%
2013-12-31โ‚น0.74 B-25.58%
2012-12-31โ‚น1.00 B1.94%
2011-12-31โ‚น0.98 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sanofi
SNY
โ‚น677.12 B 140,381.68%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น667.18 B 138,318.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น367.07 B 76,056.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น341.48 B 70,747.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น84.29 B 17,388.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel